SecBot SecBot
SC 13D/A ·Filed Oct 16, 2026

GDTC

CytoMed Therapeutics Ltd
NEUTRAL
Impact 3/10
Horizondays Processed11d 8h ago SEC0001493152-26-047321
Activist stake amendment (position change)
Actionable Insight • Neutral

The chairman's small open-market purchases signal confidence at current levels but are not material relative to his existing 25%+ stake. Monitor for any future escalation in stake size or changes to Item 4 intentions.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+5d
GDTC ▲ +4.44% at T+5d
NEUTRAL call +4.44% · α vs SPY +4.87% · entry $0.8799 → $0.9190
Next anchor: T+20d in 17d
Entry = T+0 close
Oct 16, 2026
via day close
T+1d
-3.17%
call -3.17% · α -3.59%
$0.8520
settled 8d ago
T+5d
+4.44%
call +4.44% · α +4.87%
$0.9190
settled 4d ago
T+20d
Pending
in 17d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Chairman Choo Chee Kong filed an amended Schedule 13D reporting open-market purchases of 29,250 ordinary shares between October 12-15, 2026, at a weighted average price of ~$0.8587/share, for an aggregate cost of ~$25,117. His total beneficial ownership increased to 3,003,996 shares (25.17% of outstanding), up from the prior filing. The filing is a routine insider accumulation update with no change in purpose or demands.

Key Financial Metrics

Stake
25.17%
Investor
Choo Chee Kong

Key Facts

  • Chairman Choo Chee Kong acquired 29,250 ordinary shares in open-market purchases from Oct 12-15, 2026 at ~$0.8587/share.
  • Total beneficial ownership is 3,003,996 shares, representing 25.17% of 11,934,908 outstanding shares.
  • No change in stated purpose — the filing is an amendment to report the open-market purchases and update ownership percentages.
  • The purchases were made with personal funds through a brokerage account on Nasdaq.

Financial Impact

~$25,117 aggregate purchase price for 29,250 shares at ~$0.8587/share

ownership percentage

Risk Factors

  • No material change in activist demands or strategic initiatives disclosed.
  • Small purchase size (~$25K) limits signaling value.

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13D/A Filing (Primary)0001493152-26-047321
Document: 0001493152-26-047321-index.html0001493152-26-047321
Document: 0001493152-26-047321.txt0001493152-26-047321
9 reports for GDTC
Performance horizon
33% Hit rate @ T+1 1 of 3 directional calls Went positive at some point 1 of 3 best @ T+1▲ +4.31%May 15, 2026
Filters
Rows
Reports for GDTC — sortable, filterable
TypeNow
Oct 23, 2026
4d ago
SC 13G/A
NEUTRAL ★ 3/10
$0.9190 $0.9262▲ +0.78%▲ +0.07%$0.8653 (−5.84%)
Oct 16, 2026
11d ago
SC 13D/A
NEUTRAL ★ 3/10
$0.8799 $0.8520▼ −3.17%▼ −3.59%$0.8653 (−1.66%)
Oct 13, 2026
14d ago
SC 13D/A
NEUTRAL ★ 3/10
$0.8700 $0.8599▼ −1.16%▼ −0.08%$0.8653 (−0.54%)
Oct 9, 2026
17d ago
6-K
BEARISH ★ 5/10
$0.8114 $0.8700▼ −7.22%▼ −7.23%$0.8653 (−6.64%)
Sep 30, 2026
27d ago
6-K
BEARISH ★ 5/10
$0.8430 $0.8999▼ −6.75%▼ −6.57%$0.8653 (−2.65%)
May 15, 2026
23w ago
6-K
BULLISH ★ 5/10
$1.16 $1.21▲ +4.31%▲ +4.37%$0.8653 (−25.41%)
May 11, 2026
24w ago
6-K
NEUTRAL ★ 3/10
$0.8090 $0.7690▼ −4.94%▼ −4.81%$0.8653 (+6.96%)
Mar 31, 2026
30w ago
6-K
MIXED ★ 6/10
$1.00 $1.03▲ +3.00%▲ +2.25%$0.8653 (−13.47%)
Mar 31, 2026
30w ago
20-F
NEUTRAL ★ 5/10
$1.00 $1.03▲ +3.00%▲ +2.25%$0.8653 (−13.47%)
Showing 9 of 9

US Market Status

Market Open — Closes in 1h 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 16, 2026